From January 1, 2024 to March 31, 2024, the company has repurchased 12,971,308 shares, representing 2.43% for CNY 147.82 million. With this, the company has completed the repurchase of 20,172,808 shares, representing 3.79% for CNY 243.66 million under the buyback announced on November 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.51 CNY | +3.53% |
|
0.00% | -36.63% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.63% | 60Cr | |
-5.43% | 27TCr | |
-7.99% | 8.94TCr | |
-2.18% | 3.99TCr | |
-12.60% | 3.92TCr | |
-1.82% | 3.7TCr | |
-1.49% | 3.62TCr | |
-15.99% | 3TCr | |
-4.78% | 2.92TCr | |
+4.69% | 2.37TCr |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.